Company / Revenue
MARAVAI LIFESCIENCES HOLDINGS, INC. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$185.7M
FY2025
5-year range
$185.7M / $883.0M
FY2021-FY2025
Trend
-28.3%
vs FY2024
Sector context
#91 of 155
Health Care
What the data says
At $186M, MARAVAI LIFESCIENCES HOLDINGS, INC.'s revenue ranks #91 of 155 in the Health Care sector. Revenue has declined for 3 consecutive years, from $883M in FY2022 to $186M in FY2025.
Based on SEC 10-K filings.
$186M in FY2025 with a 5-year CAGR of -8.1%.
Declined from $289M to $186M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -40.5%
- 5-Year CAGR
- -8.1%
- 10-Year CAGR
- -
Sector benchmark
#91 of 155 in Health CareTop 59% of 155This company $185.7M Sector average $4.5B
▼
-95.8% below sector average
Key checks
Key Insights
- MARAVAI LIFESCIENCES HOLDINGS, INC.'s revenue has declined for 3 consecutive years.
- 5-year CAGR of -8.1%, indicating a declining trend.
- In FY2025, revenue decreased 28.3% year-over-year.
- Ranks #91 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $185.7M | -28.3% |
| FY2024 | $259.2M | -10.3% |
| FY2023 | $288.9M | -67.3% |
| FY2022 | $883.0M | +10.5% |
| FY2021 | $799.2M | +181.3% |
| FY2020 | $284.1M | +98.5% |
| FY2019 | $143.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026